INTRODUCTION {#s1}
============

The cell cycle is an essential process for growth and development of organisms. This highly regulated process involves co-ordination of transcriptional through post-translational mechanisms. A post-translational mechanism that appears to regulate or modulate the cell cycle is the activity of a group of zinc metalloproteases in the M1 family of metalloenzymes. M1 metalloprotease functions include (*a*) small-peptide processing, often peptide hormones, (*b*) regulation of cell cycle progression (meiotic or mitotic exit), (*c*) protein trafficking and (*d*) signal transduction. Although this group of enzymes is present in all kingdoms, M1 function, i.e. enzymatic targets or interactions with other proteins, in the cell cycle is yet to be defined.

Evidence for M1 function in the cell cycle has been observed in both plant and animal loss-of-function mutants. M1 metalloprotease activity during plant growth and development have recently be observed, with meiotic prophase aminopeptidase (MPA1) important for female and male meiosis and aminopeptidase M1 (APM1) with a putative role in mitosis and cytokinesis. In plants loss-of-function results in decreased fertility from improperly formed gametes (*mpa1*) and embryo and seedling lethality from cell division arrest (*apm1*), and similar fertility and embryo lethal phenotypes have been observed in animals. Loss or impaired M1 function in mammals is also correlated with reduced fertility, type-II diabetes and cholesterol uptake. Therefore, these proteins play essential roles in meiosis and mitosis, as well as hormonal or nutrient homeostasis. This brief review will introduce the M1 metalloprotease family, the enzymatic mechanism and known functions, followed by specific examples of M1s in animals and plants and their roles in the cell cycle (Table [1](#MCQ265TB1){ref-type="table"}).

###### 

M1 metalloproteases presented in this review

  Organism                     Name                                                       Peptidase substrate(s)                                                        Non-peptidase function                          Cell cycle role
  ---------------------------- ---------------------------------------------------------- ----------------------------------------------------------------------------- ----------------------------------------------- ---------------------------------------------
  *Homo sapiens*               Aminopeptidase A (APA)                                     β-Amyloid, cholecystokinin-8, angiotensin II                                  Unknown                                         Mitosis
  *Homo sapiens*               Aminopeptidase N (APN/CD13)                                Angiotensin III, bradykinin, type-IV collagen, MHC class II peptides          Cholesterol uptake, cell surface receptor       Mitosis
  *Drosophilia melanogaster*   Aminopeptidase N (APN)                                     Unknown                                                                       Unknown                                         Mitosis; regulation of cyclin accumulation?
  *Homo sapiens*               Insulin-responsive aminopeptidase (IRAP)                   Oxytocin, vasopressin, angiotensin III, angiotensin IV, MHC type-I peptides   Trafficking                                     Insulin-dependent mitosis
  *Homo sapiens*               Endoplasmic reticulum aminopeptidase (ERAP)                HLA class I peptides                                                          Unknown                                         Unknown
  *Homo sapiens*               Leukotriene A4 hydrolase (LTA4H)                           Unknown                                                                       Leukotriene A4 hycrolase (epoxidase activity)   Unknown
  *Homo sapiens*               Puromycin-sensitive aminopeptidase (PSA)                   MHC class I peptides, tau                                                     Unknown                                         Unknown
  *Mus musculus*               Puromycin-sensitive aminopeptidase (PSA)                   MHC class I peptides                                                          Unknown                                         Mitosis; male meiosis
  *Caenorhabditis elegans*     Puromycin-sensitive aminopeptidase (PAM-1)                 Cyclin B3?                                                                    Unknown                                         Meiosis and mitosis
  *Arabidopsis thaliana*       Aminopeptidase M1 (APM1)                                   Unknown, preference for Tyr peptide substrates *in vitro*                     Trafficking                                     Mitosis
  *Arabidopsis thaliana*       Meiotic prophase aminopeptidase 1 (MPA1)                   Unknown                                                                       Unknown                                         Male and female meiosis
  *Arabidopsis thaliana*       Leukotriene A4 hydrolase-like/TAF2-like (2LTA4HL/TAF2L2)   Unknown                                                                       Unknown                                         Unknown

The M1 family of zinc metalloproteases is distinguished from other M-type proteases by signature amino acid motifs comprising the catalytic region ([@MCQ265C54]; [@MCQ265C95]; Laustsen *et al.*, 2001; [@MCQ265C77]). Substrates for this family vary widely, including acidic, basic and neutral amino acid residues. All members of the family process N-terminal amino acids, and cleave either a single amino acid or, less frequently, a series of amino acids. Substrate targets of the M1s tend to be small peptides. Evidence of endopeptidase activity has been shown for a bacterial member of the family, pepN, under stress conditions ([@MCQ265C10]). The M1 metalloproteases are also called gluzincins since they bind a single Zn ion for Zn/water hydrolysis of the substrate. In contrast to other Zn metalloenzymes where the Zn cofactor is co-ordinated by three histidines or by cysteines, the Zn-binding motif of M1 metalloproteases is HEXXH\[18X\]E, where the two histidines and a distal glutamic acid co-ordinate the Zn ion ([@MCQ265C50]) (Fig. [1](#MCQ265F1){ref-type="fig"}A). The proximal glutamic acid is required for water hydrolysis of peptide bonds and subsequent release of the substrate, as demonstrated from mutational analyses ([@MCQ265C91]). The exopeptidase domain GXMXN is the other conserved amino acid motif ([@MCQ265C35]). M1 enzymatic activities are regulated by calcium ([@MCQ265C24]), and M1 enzymes are characterized by varying degrees of sensitivity to the inhibitor puromycin, which arrests eukaryotic cells in the G~2~/M phase ([@MCQ265C11]).

![Organization and structures of M1 metallopeptidases. (A) Pictogram of an M1 metalloprotease showing the enzymatic domains (light blue), hydrophobic domain (dark blue) and protein--protein interaction domains (magenta). The zinc-binding amino acids are highlighted in red. (B) Crystal structures (from the Research Collaboratory for Structural Bioinformatics Protein Database) of M1 metallopeptidases: *Escherichia coli* aminopeptidase N (pepN) in complex with phenylalanine (3B34) ([@MCQ265C2]); tricorn interacting factor F3 from *Thermoplasma acidophilum* (1Z5H ) ([@MCQ265C49]); soluble domain of human endoplasmic reticulum aminopeptidase 1 ERAP1 (2XDT) ([@MCQ265C96]); LTA4H in complex with Arg-Ala-Arg substrate (3B7T) ([@MCQ265C90]). The zinc ion is represented by a blue (pepN, ERAP) or grey (tricorn F3, LTA4H) sphere.](mcq26501){#MCQ265F1}

Soluble, membrane-associated, or membrane-anchored M1 peptidases have been identified. Hydrophobic domains in the N-terminus of the proteins can either form a membrane-spanning anchor or a protein--protein interaction domain in peripheral membrane M1 isoforms ([@MCQ265C15]; [@MCQ265C8]; [@MCQ265C43]; [@MCQ265C74]). Integral membrane M1s represent a small subset of these enzymes and have the catalytic region exterior to the cell, while the catalytic sites of peripheral membrane proteins are on the cytosolic face. In some instances, the same protein has both soluble and membrane-associated forms ([@MCQ265C15]; [@MCQ265C65]; [@MCQ265C74]). Further, some soluble M1s are secreted and, therefore, may be active both inside and outside of the cell (Fig. [2](#MCQ265F2){ref-type="fig"}A).

![Models of M1 interactions. (A) A peripheral membrane-associated M1 may be active in the endosomal population and at the plasma membrane (PM). It may also interact with other proteins in the endosome or PM and modulate their functions, such as signal transduction or processing peptides that are exported to or imported from the extracellular space. (B) An integral membrane M1 may have the same activity as a peripheral membrane M1. (C) M1 proteins may also co-traffic proteins to the PM. An example is the insulin-induced IRAP-mediated GLUT4 trafficking to the PM in mammals. (D) M1 proteins may mediate uptake of cargo from the extracellular space via protein-interacting partners. This activity may be independent from their enzymatic activity, such as cholesterol uptake by APN in mammals. M1 proteins may also be secreted into the extracellular space (A) or cleaved and released from the PM (C).](mcq26502){#MCQ265F2}

Many M1s function as homodimers, and others form heterodimers with other types of proteins ([@MCQ265C32]; [@MCQ265C34]; [@MCQ265C6]; [@MCQ265C53]; [@MCQ265C67]). C-terminal protein--protein interaction domains often co-ordinate the interactions of M1 oligimerization events. Homodimers may be formed via disulfide linkages or non-covalent interactions ([@MCQ265C28]; [@MCQ265C72]; [@MCQ265C69]). Both integral and peripheral M1s may have additional dileucine protein interaction motifs that function in recycling and retention of the proteins in endosomal populations ([@MCQ265C79]; [@MCQ265C36]; [@MCQ265C42]; [@MCQ265C12]). These motifs are generally found in the C-terminus, although mammalian insulin-responsive aminopeptidase (IRAP)/oxytocinase contains a unique N-terminal trafficking domain ([@MCQ265C29]).

M1s appear to be multi-functional proteins, with some functions related to enzymatic activity and others independent of enzymatic activity ([@MCQ265C47]), although the majority of M1s require an active catalytic domain for function ([@MCQ265C4]; [@MCQ265C74]). For example, M1 membrane association, trafficking to the plasma membrane, and M1-mediated trafficking of proteins to the plasma membrane require active catalytic domains ([@MCQ265C69]; [@MCQ265C4]; [@MCQ265C30]). In contrast, cholesterol endocytosis in the intestine involves M1 protein--protein interactions independent of M1 enzymatic activity ([@MCQ265C47]; Fig. [2](#MCQ265F2){ref-type="fig"}D).

As mentioned above, M1 metalloproteases are found among all kingdoms, except viruses (Fig. [3](#MCQ265F3){ref-type="fig"}). Plant, animal and archaea M1s fall into the same clade, with subclades for some animal proteins, such as the oxyocinase family comprised of the insulin-responsive aminopeptidase (IRAP/oxytocinase/P-LAP) and the endoplasmic reticulum aminopeptidases (ERAP1/2; [@MCQ265C30]). The fungi form their own clade, as do the prokaryotes ([@MCQ265C30]). Outlying members of the M1 family have homology to other proteins, and therefore are more distantly related. Examples include non-peptidase homologues, such as AC3·5 from *Caenorhabditis elegans*, while others have dual enzymatic functions, such as human leukotriene A4 hydrolase (LTA4H) possessing both aminopeptidase and epoxide hydrolase activities ([@MCQ265C92]). The Zn-binding motif is shared between aminopeptidase and epoxide hydrolase activities in LTA4H (Fig. [1](#MCQ265F1){ref-type="fig"}B).

![Dendogram of M1 metalloproteases. Representatives from the different kingdoms are shown based on the MEROPS classification system. Bootstrap values are indicated at branch points. M1 metallopeptidases in bold are discussed in the text. Adapted from [@MCQ265C30].](mcq26503){#MCQ265F3}

ANIMAL M1 METALLOPROTEASES {#s2}
==========================

Both soluble/non-transmembrane and integral membrane M1 metallopeptidases are present in animals. Humans have nine M1s: six transmembrane proteins (aminopeptidase A, aminopeptidase N, insulin-regulated aminopeptidase, endoplasmic reticulum aminopeptidase 1 and 2 and thyrotropin-releasing hormone-degrading ectoenzyme) with the catalytic domain outside of the cell, and three soluble proteins (puromycin-sensitive aminopeptidase, aminopeptidase B and leukotriene A4 hydrolase; [@MCQ265C89]; reviewed in [@MCQ265C4]). Soluble forms of aminopeptidase N (APN) and IRAP have been identified in serum. While thyrotropin-releasing hormone-degrading ectoenzyme has only one substrate, other M1s have multiple substrates, depending on tissue-specific expression as well as subcellular distribution. Leukotriene A4 hydrolase is discussed below in reference to plant M1s; aminopeptidase B shows strong structural similarity to LTA4H, cleaves basic N-terminal amino acids, and can process glucagon into miniglucagon ([@MCQ265C17]; [@MCQ265C77]).

APA {#s2a}
---

Aminopeptidase A (APA), also known as angiotensinase and glutamyl aminopeptidase, is membrane bound and cleaves N-terminal acidic residues, although soluble forms have been found in serum and urine. APA can cleave β-amyloid, which is implicated in Alzheimer\'s disease ([@MCQ265C84]). APA is also important in processing signalling peptides, such as the eight-amino acid peptide cholecystokinin-8, which increases nerve growth factor transcription ([@MCQ265C56]). APA cleaves the small eight-amino acid hormone angiotensin II (AngII) to AngIII in the brain ([@MCQ265C59]), resulting in release of vasopressin which acts in blood pressure regulation. However, in peripheral organs, AngII cleavage may be part of protein metabolism. Inhibition of APA enzymatic activity resulted in inhibition of B precursor cell proliferation ([@MCQ265C99]), and the author suggests that a small peptide inhibitor of B cell proliferation is cleaved by APA, which allows cell proliferation to proceed.

APN {#s2b}
---

Aminopeptidase N (APN), sometimes called alanyl aminopeptidase or CD13, is a heavily glycosylated protein, and plays a role in regulating blood pressure by converting the seven-amino acid AngIII to AngIV to abrogate the effects of AngIII. APN can process a number of peptide substrates including the kinins (e.g. bradykinin) and type-IV collagen, and generates MHC type-II peptides. However, not all of APN function is dependent on its enzymatic activity. It also appears to act as a receptor and a signalling molecule (reviewed in [@MCQ265C58]). However, these functions are likely to include other protein partners.

APN acts as receptor for corona viruses ([@MCQ265C45]; [@MCQ265C94]), and appears to function in cholesterol uptake independent of its enzymatic activity ([@MCQ265C100]; [@MCQ265C47]). APN endocytosis is regulated by the protein RECK (reversion-inducing cysteine-rich protein with Kazal motifs) ([@MCQ265C57]), and trafficking may be a mechanism to regulate APN function at the plasma membrane.

As a signalling molecule, APN mediates release of calcium from intracellular stores and subsequent phosphorylation of specific mitogen-activated protein kinases (MAPKs) in monocytes ([@MCQ265C81]). APN acts as membrane receptor for a 14-3-3σ protein, stratifin, which results in p38 MAPK cascade to stimulate matrix metalloproteinase-1 expression in fibrobasts ([@MCQ265C22]). Knockdown of APN resulted in decreased 14-3-3σ binding at the cell surface and decreased expression of matrix metalloproteinase-1, which is involved in tumour metastasis. Therefore, APN appears to have a role in cell migration or cell adhesion, also consistent with an enzymatic activity against type-IV collagen.

Another function of APN is suggested from a study in insects. In a genetic screen in *Drosopilia*, the *APN* loss-of-function allele *slamdance* was identified as suppressor of *rougheyes in rap*/*fzr* (*fizzy-related*; [@MCQ265C40]). FZR is a component of the anaphase-promoting complex, which degrades cyclins during G~1~ and G~2~. *FZR* loss-of function mutants have an extra cell division in the epidermis and endoreduplication is inhibited in salivary glands ([@MCQ265C86]). Therefore, suppression of the *fzr* mutant phenotype by the loss of APN suggests that APN may play a role in cell cycle progression by regulating cyclin accumulations. In mammalian monocytes, APN cell surface localization is modulated by the cell cycle, with a decrease observed during S phase ([@MCQ265C52]), and the authors hypothesize, based on inhibition of APN activity by antibodies, that APN acts as a ligand receptor or processes peptides that inhibit cell cycle rates. This is similar to what is seen with respect to proposed APA function in B cell proliferation.

IRAP and ERAPs {#s2c}
--------------

The insulin-responsive aminopeptidase (IRAP) has many synonyms, including angiotensin IV receptor, cystinyl aminopeptidase, leucyl-cystinyl aminopeptidase, oxytocinase, placental leucine aminopeptidase and vasopressinase, based upon the tissue in which the activity was identified. These were subsequently shown to be the same protein. Soluble IRAP (oxytocinase, placental leucine aminopeptidase, vasopressinase) is found in the serum and regulates the amounts oxytocin and vasopressin during pregnancy in humans, but not in mice ([@MCQ265C76]). However, IRAP is usually found as a transmembrane protein localized on the plasma membrane or in endosomal populations.

One specialized endomembrane population of IRAP localizes with glucose transporter 4 (GLUT4) in specialized insulin-responsive compartment in adipose and muscle tissue, and IRAP is the only protein known to co-localize with GLUT4 through secretion ([@MCQ265C73]) (Fig. [2](#MCQ265F2){ref-type="fig"}C). This highly regulated insulin-inducible trafficking of GLUT4 and IRAP to the plasma membrane is mediated by a protein--protein interaction motif in the N-terminus of IRAP with AS160, an Akt with phosphorylation and Rab GTPase activating activity ([@MCQ265C73]). Recycling of IRAP from the plasma membrane back to the insulin-responsive compartment requires the Q-SNARE syntaxin 6 ([@MCQ265C98]). Targeting of IRAP to the insulin-responsive compartment, both initially, and in retrograde trafficking, is dependent upon one dileuicine motif in the N-terminus ([@MCQ265C98]).

Insulin induces IRAP localization to the plasma membrane, where IRAP may cleave small peptide hormones such as oxytocin and vasopressin. In adrenal membranes and brain, IRAP was identified as the AngIV receptor, which regulates blood pressure and learning/memory ([@MCQ265C3]). IRAP can also cleave AngIII to AngIV, which is a competitive inhibitor of IRAP catalytic activity ([@MCQ265C51]; [@MCQ265C4]). Therefore, the AngIV cleavage product, produced by APN or IRAP activity, appears to inhibit IRAP activity to rectify the effects of AngIII. Therefore both membrane-bound and soluble IRAP can decrease the effects of AngIII by attenuating the signal and degrading the secreted product. An additional role of IRAP at the plasma membrane may be to cleave cell proliferation inhibitors and promote angiogenesis in tumour cells. IRAP has been shown to increase cell proliferation in endometrial cancer cells ([@MCQ265C85]). The increase in IRAP in tumour cells was concurrent with increases in GLUT4, the insulin receptor and AKT phosphorylation ([@MCQ265C85]).

The endoplasmic reticulum aminopeptidases, ERAP1 (adipocyte-derived leucine aminopeptidase) and ERAP2 (leukocyte-derived arginine aminopeptidase), form a heterodimer and are involved in post-proteosome processing generation of HLA class I antigenic peptides in immune response ([@MCQ265C23]; [@MCQ265C82]), and is not redundant with post-proteosome antigen processing of some IRAP endosomal populations ([@MCQ265C23]; [@MCQ265C21]). In addition, ERAP1 and 2 appear to have a role in pathogenesis of ankylosing spondylitis, and ERAP1 has been implicated in shedding of cytokine receptors from the cell surface to attenuate signalling (reviewed in [@MCQ265C26]).

PSA/PAM-1 {#s2d}
---------

The puromycin-sensitive aminopeptidase (PSA) from mammals is a soluble protein with both cytosolic and nuclear localization ([@MCQ265C11]). Like other M1s, PSA is able to process MHC class I peptides, as well as small peptides, and may have a role in cellular trafficking. PSA associates with microtubules in the spindles during mitosis, and inhibition of PSA also results in apoptosis in the absence of nascent protein synthesis ([@MCQ265C11]). In mice, *PSA* loss-of-function lines have fewer viable embryos resulting in reduced litter size, and are smaller and less fertile, or infertile, compared with wild type, indicating that PSA is required for normal growth ([@MCQ265C70], [@MCQ265C71]; [@MCQ265C93]). However, the target of PSA in cell cycle function is unknown.

The microtubule stabilizing protein tau is an *in vitro* and *in vivo* target of PSA which was identified in a yeast two-hybrid screen for targets of PSA activity ([@MCQ265C41]; [@MCQ265C83]; [@MCQ265C102]). Tau degradation by PSA is independent of the proteasome ([@MCQ265C83]; [@MCQ265C102]). PSA is localized in neurons, consistent with a role in degrading tau proteins which accumulate in Parkinson\'s disease.

PAM-1, the puromycin-sensitive aminopeptidase from *C. elegans*, is the orthologue of the mammalian PSA ([@MCQ265C105]), although it is less puromycin sensitive than other M1s ([@MCQ265C104]). *PAM-1* loss-of-function mutants are arrested in meiosis. PAM-1 may regulate cyclin B3 activity as inactivation of cyclin B3 in *pam-1* rescues the mutant and meiotic exit occurs ([@MCQ265C105]). PAM-1 is localized at the centrosome during mitosis and is required for oocyte-to-embryo transition and establishment of anterior--posterior (A-P) polarity, although inactivation of cyclin B did not rescue the polarity defect in *pam-1* ([@MCQ265C105]; [@MCQ265C18]). The A-P axis is formed in the single-celled embryo by migration of the sperm-donated centrosomes to signal the posterior axis, which is aberrant in *pam-1* mutants ([@MCQ265C18]). When microtubules were inhibited in *pam-1*, the A-P axis was restored, and cell division proceeded ([@MCQ265C18]). PAM-1 therefore seems to have different targets in meiosis (cyclin B3) and mitosis/A-P axis formation (microtubules, microtubule-associated protein), although a similar phenotype of cell cycle arrest is observed in both cases.

PLANT M1 METALLOPROTEASES {#s3}
=========================

The arabidopsis M1 aminopeptidase family consists of three members (Fig. [3](#MCQ265F3){ref-type="fig"}). The bryophyte *Physcomitrella patens* has one member in the plant/animal/archaea clade, as does *Arabidopsis thaliana*, whereas a duplication event appears to have occurred following the dicot/monocot split, and *Oryza sativa* has two members in this clade. In the prokaryotic clade, both rice and arabidopsis have one member each, while *P. patens* has two members. In an outlying M1 group which is anchored by human TATA box binding protein-associated factor 2 (TAF2), one M1 member is found in rice and arabidopsis ([@MCQ265C30]).

APM1 {#s3a}
----

*Aminopeptidase M1* (*APM1*, At4g33090, GAMEN, HELAH\[X18\]E) is the single arabidopsis member of the plant/animal/archaea clade. APM1 is a peripheral membrane protein that was identified by its specificity for the non-competitive auxin transport inhibitor *N*-1-naphthylphthalmic acid (NPA) and the ability to slowly hydrolyse the compound ([@MCQ265C62], [@MCQ265C63]; [@MCQ265C64], [@MCQ265C65], [@MCQ265C66]; [@MCQ265C87]; [@MCQ265C74]; [@MCQ265C30]). The structure of NPA is similar to phthalamide which inhibits M1 activity in animals and plants ([@MCQ265C46]; [@MCQ265C65]; [@MCQ265C39]). At high concentrations, NPA inhibits APM1 activity, and exhibits increasing inhibition over time ([@MCQ265C62]; [@MCQ265C65]). Although the mechanism of NPA inhibition of APM1 activity is not known, NPA binds in the active site of APM1, which cleaves the amide bond of NPA. However, the phthalic acid may not be released from the active site or NPA may also bind to an allosteric site in APM1, thereby resulting in an inactive enzyme. NPA binding appears to destabilize APM1, as neither dimers nor monomers are observed after NPA treatment ([@MCQ265C30]).

Enzymatic activity was shown by *in vitro* assays from purified protein as well as protein expressed in wheat germ extract, rabbit reticulocytes and *Escherichia coli* ([@MCQ265C65]; [@MCQ265C30]). Although MEROPS classifies APM1 as a cytosol alanyl aminopeptidase, experimentally APM1 shows the greatest metallopeptidase activity against tyrosine residues. The order of activity against small peptide substrates or to amino acid 7-amino-4-trifluoromethyl-coumarin conjugates are Tyr ≫ Ala \> Pro ≫ Trp = Leu ([@MCQ265C65]; [@MCQ265C30]). APM1 forms a dimer, and it appears that the dimer is the active form *in planta*, although the monomer shows enzymatic activity at least equal to that of the dimer *in vitro* ([@MCQ265C65]; [@MCQ265C30]). APM1 activity is sensitive to puromycin, bestatin, apstatin (substrate mimics) and PAQ-22/PIQ-22 ([@MCQ265C65]), which binds at an allosteric site and is specific for PSA ([@MCQ265C39]).

Loss-of-function mutants show embryo lethality and cessation of primary root growth at 5 d after germination ([@MCQ265C74]). Site-directed mutagenesis studies have identified amino acid residues and regions of the protein that are essential for its function, as assayed by the ability of the overexpressed mutated construct to rescue the *apm1* embryo lethal or root growth arrest phenotypes ([@MCQ265C30]). A β-pleated region in the N-terminus appears to mediate membrane association, and a region of the C-terminus is also essential for APM1 activity. Although mutation of the zinc-binding domain did not rescue any phenotypes, mutation of the exopeptidase domain resulted in partial restoration of embryo lethality in *apm1-1*, suggesting that exopeptidase activity may be less important during embryo development ([@MCQ265C30]). However, overexpression of a catalytically inactive APM1 in *apm1-2*, which accumulates a truncated protein missing the C-terminus, rescues the mutant. In addition, the same results are obtained when *apm1* mutants are transformed with catalytically active or inactive IRAP, also indicating conservation of M1 function across kingdoms. These results also indicate that one intact copy of the catalytic domain and one intact copy of the C-terminus are required for APM1 function, and that the domains need not be in the same linear molecule ([@MCQ265C30]). As mentioned above, the C-terminus of M1s often have protein interaction motifs. The C-terminus of APM1 may be important for its dimerization or interaction with other proteins. Candidate proteins with which APM1 may interact were identified via co-purification ([@MCQ265C65]), and co-immunoprecipitation, yeast two-hybrid, yeast three-hybrid and split-ubiquitin assays. However, more experiments are needed to conclude which proteins interact with APM1 and which proteins are substrate targets.

Diacidic motif scanning identified one dileucine pair (of 13) that is required for APM1 function ([@MCQ265C30]). Dileucines are part of endocytosis motifs \[ED\]XXXL\[LI\] recognized by the adaptor protein complexes and are important in targeting proteins to organelles ([@MCQ265C31]; [@MCQ265C44]; [@MCQ265C98]). This dileucine motif is proximal to the essential region of the C-terminus mentioned above. APM1 is enriched in light membrane microsomal fractions and shows localization in endosomes, the plasma membrane and at the forming cell plate, consistent with a hydrophobic region in the N-terminus ([@MCQ265C65]; [@MCQ265C74], [@MCQ265C30]). Additional evidence supporting that APM1 trafficks to and from the plasma membrane is provided by electron microscopy immunolocalizations ([@MCQ265C74]). APM1 also co-purified with adaptor protein subunits, as well as plasma membrane localized auxin transporters ([@MCQ265C65]). *APM1* loss-of-function lines show mistargeting of PIN2 and ABCB19 transporters to the plasma membrane ([@MCQ265C74]). APM1 subcellular localization, shown by immunolocalizations and functional fluorescent-protein fusions, is sensitive to the trafficking inhibitors that affect PIN2 localization ([@MCQ265C74]).

As mentioned above, *APM1* loss-of-function lines exhibit root growth arrest 5 d after germination, the peak time of *APM1* expression. Root growth arrest can be attributed to (*a*) premature determinacy of the root meristem, as shown by cessation of quiescent centre activity, and (*b*) cell cycle arrest, as shown by absence of *cyclinB1;1* expression ([@MCQ265C74]). Several factors maintain the quiescent centre including non-cell autonomous transcription factors (e.g. SHORTROOT, SCARECROW), mobile small peptide hormones (e.g. CLAVATA3/ESR-related CLE proteins), and the hormone auxin. *SHR* and *SCR* are misexpressed or mislocalized in *apm1* lines, resulting in mis-specification of the ground tissue ([@MCQ265C74]). *APM1* expression increases in the presence of auxin in a two-stage manner, suggesting both a primary auxin response and a secondary response which is usually associated with wounding or defence ([@MCQ265C74]), and the promoter contains an auxin-responsive element (TGTCAT; [@MCQ265C14]), consistent with increased expression following auxin application. A putative zinc carboxypeptidase SOL1 was identified in a *CLE19* overexpression screen, suggesting that CLE may be activated by SOL1 activity ([@MCQ265C9]). Although the substrate(s) for APM1 are yet to be identified, one of the CLE proteins is a possible candidate for activation/deactivation by APM1. The absence of *cyclinB1;1* expression in the *apm1-1* suggests that the mutants may be arrested in G~2~/M or never reached that stage ([@MCQ265C74]). The *APM1* promoter contains signature sequences associated with cell cycle regulation (GCCCR; [@MCQ265C5]), supporting that *APM1* expression may be tied to the cell cycle. At least two other M1 metalloproteases have been implicated in meiotic or mitotic exit (PSA and PAM-1), while APN may regulate or act as a component of the anaphase-promoting complex. Therefore, it seems likely that APM1 may also play a role in cell cycle progression that is yet to be elucidated.

APM1 also appears to be involved in cytokinesis. Immuno- and functional fluorescent-protein fusion localizations of APM1 show signals at the forming cell plate, apparently at the leading edges ([@MCQ265C74]). Loss-of-function mutants show irregular planes of cell division in mutants, supporting a role for APM1 in cell division ([@MCQ265C74]). Since the planes of cell division are mis-specified, APM1 may play a role in polarity with respect to placement of the pre-prophase band, in addition to a role in cell plate formation.

Immunolocalizations show APM1 signals in the maturing xylem elements while loss-of-function mutant show mis-specification of ground tissue and irregular vasculature ([@MCQ265C74]). Northern blot ([@MCQ265C65]) and microarray analyses (Genevestigator, eFPBorwser) show that *APM1* is also highly expressed in senescing leaves. The end result of xylem maturation and senescence is dead cells. This suggests a role for APM1 in programmed cell death; either a direct role in apoptosis or a role in recycling of proteins/amino acids in this process is yet to be determined.

MPA1 {#s3b}
----

*Meiotic prophase aminopeptidase 1* (*MPA1*, At1g63770, GAMEN, HEYFH\[X18\]E) is the single M1 arabidopsis member of the prokaryotic clade ([@MCQ265C30]), and MEROPS places it as bacterial-type alanyl aminopeptidase. Unlike *APM1* and *TAF2L2*/*LTA4HL* (see below) which have one gene model each, *MPA1* has four different gene models, suggesting the possibility of spatio-temperal regulation. Based on amino acid motif analysis, MPA1 appears to be a soluble protein that lacks the N-terminal hydrophobic and C-terminal protein--protein interaction domains present in APM1. The enzymatic activity of MPA1 has not been described; however, treatment of inflorescences with a fluorescent version of the M1 inhibitor PAQ22 phenocopied a meiotic defect observed in the loss-of-function mutant ([@MCQ265C80]). The semi-sterile phenotype was also attributed to inhibition of MPA1 activity ([@MCQ265C80]), but the observed embryo abortion was likely an aggregation of inhibition of MPA1 during gametogenesis and APM1 during embryogenesis.

MPA1 appears to regulate cell cycle progression during meiosis in both female and male gametophytes ([@MCQ265C80]). In *mpa1*, a combination of defects is observed during meiosis, beginning with abnormal synapsis. Incomplete synapsis occurred 4-fold more frequently than wild type with a 90 % decrease in homologous crossovers, and the chromosome pairs were not linked by chiasmata ([@MCQ265C80]). In *mpa1*, the recombination protein RAD51 is destabilized and the mismatch repair protein MSH1 is mislocalized ([@MCQ265C80]), resulting in high disjunction frequencies during anaphase I for chromosomes 2, 4 and 5 which carries over through meiosis II ([@MCQ265C78]). However, spindle formation appears to be normal in *mpa1* mutants ([@MCQ265C80]). One possible scenario is that MPA1 is necessary for synaptonemal complex formation and subsequent dissociation.

*MPA1* is expressed in somatic tissues as well (Genevestigator, eFPBowser), and MPA1 appears to be a cytosolic protein that is also normally present in the apoplast ([@MCQ265C38]). Proteomics of the arabidopsis extracellular space following *Pseudomonas syringae* infection indicates that abundance of MPA1 in the apoplast was increased by type-III effectors (TTEs) but decreased by microbe-associated molecular patterns (MAMPs) as well as gene-for-gene resistance ([@MCQ265C38]). Bacterial MAMPs, e.g. flagellin, induce the basal defence system in plants via a receptor-like kinase-mediated signal transduction cascade. Bacterial TTEs overcome the MAMP-activated resistance by affecting cellular responses, from mitogen-activated protein kinases ([@MCQ265C103]) to RNA metabolism ([@MCQ265C19]). The MAMP-associated decrease in apoplastic MPA1 may be either through bacterial degradation of MPA1 or suppression of MPA1 secretion ([@MCQ265C38]). The presence of MPA1 outside of the cell suggests that MPA1 may also have a role in basal defence responses or modification of extracellular peptides. Increased extracellular MPA1 accumulation by TTEs suggests that MPA1 activity provides metabolic products for the pathogen.

TAF2L/LTA4HL {#s3c}
------------

A *TAF2-like 2* (*TAF2L2*)/*leukotriene A4 hydrolase-like* (*LTA4HL*) gene is found in arabidopsis (*At5g13520*, GGMEN, HELAH\[X18\]E). The function(s) of this protein is unknown. MEROPS places it as cold-active aminopeptidase (*Colwellia psychrerythraea*)-type peptidase. Aminopeptidase activity has been reported for this protein ([@MCQ265C97]), but LTA4H/epoxide hydrolase activity has not been examined. In animals, leukotrienes are fatty acids that are lipid signalling molecules acting via G-coupled protein receptors ([@MCQ265C25]), and plant compounds are used therapeutically to inhibit leukotriene synthesis/activity ([@MCQ265C1]). Plants are not considered to synthesize leukotrienes (nor the arachidonic acid precursor), although there is one report of LTB4 and LTC4 accumulation in nettle glandular trichomes ([@MCQ265C13]). Epoxide hydrolases in plants are associated with conversion of fatty acids stores in seeds and synthesis of cutins for defence ([@MCQ265C88]; [@MCQ265C7]). Leukotrienes are synthesized by a complex of enzymes, with the soluble LTA4H having both cytosolic and nuclear localization ([@MCQ265C68]). A biological function for human LTA4H aminopeptidase activity has not been demonstrated. Overexpression (35S) constructs of *At5g13520* show nuclear localization, as well as cytosolic localization ([@MCQ265C30]). *At5g13520* was expressed in the *apm1-3* loss-of-function lines which showed heterodimerzation of the mutant APM1 protein and TAF2L2/LTA4HL, with the observed cytosolic localization attributed to the herterodimer ([@MCQ265C30]). That being said, more research needs to be conducted with native promoters, and the subcellular localization suggests that this protein may be involved in (*a*) processing transcription factor-associated proteins or small peptide hormones in the nucleus and/or (*b*) fatty acid biosynthesis/metabolism.

Like *C. elegans* AC3·5, arabidopsis has a non-peptidase M1 homologue (At1g73960, TAF2L1), which is in the TAF2 group (MEROPS). *TAF2L1* has two different gene models and its function is unknown.

CONSERVATION OF FUNCTION AND ROLES OF PLANT M1 METALLOPROTEASES {#s4}
===============================================================

M1 metalloproteaes appear to be multifunctional proteins, and their functions are required for normal cell growth and activity. M1 enzymatic function is required for cell cycle regulation in both meiosis and mitosis and for processing small peptides, such as hormones, for growth and antigens for defence. M1s can function as classical receptors and participants in signal transduction. They participate in cellular trafficking of transporters, directly or indirectly, and sterols. Some of M1 function in these processes is dependent on microtubule associations or degradation of microtubule-associated proteins. However, it is unclear if M1 function is independent of catalytic activity due to the small number of studies of enzymatically inactive proteins. These studies are difficult as loss-of-function is often lethal.

Post-proteasome and proteasome-independent peptide processing have been demonstrated in animals, but proteasome-associated peptide processing has not been directly observed. M1 aminopeptidases in plants may be associated with the proteasome/anaphase-promoting complex. The anaphase-promoting complex itself has been shown to have a dual function. For example, arabidopsis CDC27B/HOBBIT functions in the anaphase-promoting complex in gametogenesis, mitosis ([@MCQ265C75]) and regulation of plant defence responses ([@MCQ265C48]).

Conservation of function between the plant and animal kingdoms is demonstrated by the ability of IRAP to rescue *apm1* embryo and growth defects. An hypothesis of APM1 function was based on hormone-induced trafficking of a transporter to the plasma membrane, i.e. auxin-induced trafficking of APM1 and an auxin transporter to the plasma membrane as an analogue of insulin-induced trafficking of IRAP and GLUT4 to the plasma membrane. This model was based on co-purification of APM1 with auxin transporters and trafficking components ([@MCQ265C60]; [@MCQ265C65]; [@MCQ265C61]). Although this hypothesis has not been fully tested, it appears that APM1 effects on auxin transporter localization are indirect ([@MCQ265C74]). It seems more likely that APM1 may function like APN or PSA/PAM-1.

The role of APM1 in the switch between an indeterminate and determinate root meristem may lie in nutritional homeostasis, small-peptide processing or anaphase-promoting complex activity or a combination of the above. A potential role of APM1 in nutritional homeostasis may lie in N-terminal peptide processing, perhaps as part of the proteasome, to supply the free amino acid pools for *de novo* protein synthesis or nitrogen availability for growth. Small peptide hormones and signalling molecules, e.g. CLE, have been shown to regulate and maintain the meristem and occur as gradients in the root with some CLE proteins promoting meristem maintenance and others vascular differentiation via phospholipid signalling ([@MCQ265C27]; [@MCQ265C101]; [@MCQ265C20]; [@MCQ265C55]). Since overexpression or exogenous application of CLE results in root meristem consumption ([@MCQ265C16]; [@MCQ265C33]), APM1 may serve to attenuate the signal. APM1 activity could also attenuate tracheary element differentiation inhibitory factors which share sequence identity with CLEs ([@MCQ265C33]). This hypothesis is consistent with APM1 localization pattern, the *apm1* mutant phenotypes and tissue-specific substrates observed for animal M1 metalloproteases. The *APM1* promoter contains three GCCCR elements, indicating that its expression is regulated by the cell cycle, and it may regulate cell cycle checkpoints as does PSA. MPA1 activity in meiosis appears to be clear, although the substrate and mechanism of its action is not known, while the function of extracellular MPA1 is unknown. The function of TAF2L2/LTA4HL is also unknown. Many outstanding questions remain, which can only begin to be answered when both peptide substrates and protein partners for M1 metalloproteases are identified.

FUTURE DIRECTIONS {#s5}
=================

Efforts to identify aminopeptidase substrates in plants have been unsatisfactory due to lack of technological advances required to identify products of single amino acid hydrolysis from peptides *in planta*. Proteomics approaches, such as two-dimensional electrophoresis, cannot distinguish such small changes. In addition, the activity of the aminopeptidase may be followed by other hydrolytic events, thereby obscuring the aminopeptidase activity of interest. Protease inhibitors, such as MG132 which is specific for the proteosome, have been used to distinguish between proteosome-dependent and -independent activities. Combinations of protease inhibitors have also been used, but these are not always specific, and then definitive results cannot be obtained. For example, bestatin is a strong inhibitor of M24 metalloproteases and M1s to a lesser extent, therefore an inhibited M1 activity may be incorrectly attributed to M24. The sensitivity of M1s to inhibitors should be revisited which would better inform this approach. An approach that may be more fruitful is to change the enzyme into a substrate-binding protein without catalytic activity. This should lead to identification of physiologically relevant substrates from plant cell extracts. Understanding the function of APM1 and MPA1 in the cell cycle in plants has clear implications for understanding of M1 function in the cell cycle and development in other organisms.

I thank Angus Murphy for his support and encouragement, our on-going collaboration, and for helpful comments on this manuscript. This work was funded by NSF-IOS 0820648.
